Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Rocket Pharmaceuticals Inc (RCKT)

Rocket Pharmaceuticals Inc (RCKT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,326,741
  • Shares Outstanding, K 75,684
  • Annual Sales, $ 0 K
  • Annual Income, $ -169,070 K
  • 60-Month Beta 1.48
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 3.83
Trade RCKT with:

Options Overview Details

View History
  • Implied Volatility 71.40% ( -1.70%)
  • Historical Volatility 80.07%
  • IV Percentile 7%
  • IV Rank 12.29%
  • IV High 182.46% on 09/21/22
  • IV Low 55.83% on 09/09/22
  • Put/Call Vol Ratio 0.14
  • Today's Volume 116
  • Volume Avg (30-Day) 209
  • Put/Call OI Ratio 0.92
  • Today's Open Interest 3,643
  • Open Int (30-Day) 3,571

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate -0.75
  • Number of Estimates 7
  • High Estimate -0.40
  • Low Estimate -0.90
  • Prior Year -0.69
  • Growth Rate Est. (year over year) -8.70%

Price Performance

See More
Period Period Low Period High Performance
1-Month
14.86 +21.67%
on 11/04/22
21.45 -15.71%
on 11/15/22
-0.86 (-4.54%)
since 10/28/22
3-Month
11.78 +53.48%
on 09/23/22
21.45 -15.71%
on 11/15/22
+2.52 (+16.20%)
since 08/29/22
52-Week
7.57 +139.00%
on 05/12/22
25.62 -29.43%
on 12/08/21
-5.59 (-23.62%)
since 11/26/21

Most Recent Stories

More News
Rocket Pharmaceuticals to Present at the 5th Annual Evercore ISI HealthCONx Conference

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a leading late-stage biotechnology company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders with high unmet...

RCKT : 18.08 (+3.14%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SBCF, RCKT, CLR, USER

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

SBCF : 33.87 (+0.83%)
RCKT : 18.08 (+3.14%)
CLR : 74.27 (+0.04%)
USER : 7.40 (-0.13%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RCKT, RCOR, SMBC, TALO

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

RCKT : 18.08 (+3.14%)
RCOR : 3.05 (+5.17%)
SMBC : 51.63 (-0.71%)
TALO : 19.33 (+1.63%)
RENOVACOR INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Renovacor, Inc. - RCOR

/PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the...

RCOR : 3.05 (+5.17%)
RCKT : 18.08 (+3.14%)
Rocket Pharmaceuticals Reports Third Quarter 2022 Financial Results and Highlights Recent Progress

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a leading late-stage, clinical biotechnology company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders with...

RCKT : 18.08 (+3.14%)
Rocket Pharmaceuticals Announces Presentations Highlighting AAV and Lentiviral Gene Therapies at Upcoming Scientific Congresses

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a leading late-stage, clinical biotechnology company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders with...

RCKT : 18.08 (+3.14%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates EQ, RCKT, RMED, RCOR

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

EQ : 1.6500 (-1.79%)
RCKT : 18.08 (+3.14%)
RMED : 2.11 (-5.38%)
RCOR : 3.05 (+5.17%)
Wall Street Analysts See an 184% Upside in Rocket Pharmaceuticals (RCKT): Can the Stock Really Move This High?

The mean of analysts' price targets for Rocket Pharmaceuticals (RCKT) points to an 183.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement...

RCKT : 18.08 (+3.14%)
RENOVACOR INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Renovacor, Inc. - RCOR

/PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the...

RCOR : 3.05 (+5.17%)
RCKT : 18.08 (+3.14%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FORG, KNBE, AAWW, RCKT

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

FORG : 21.78 (+0.46%)
KNBE : 24.68 (-0.04%)
AAWW : 100.70 (+0.01%)
RCKT : 18.08 (+3.14%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Rocket Pharmaceuticals, Inc. is an emerging, clinical-stage biotechnology company. It focused on developing first-in-class gene therapy treatment options for rare, undertreated diseases. Rocket Pharmaceuticals Inc., formerly known as Inotek Pharmaceuticals Corporation, is based in LEXINGTON, United States....

See More

Key Turning Points

3rd Resistance Point 19.42
2nd Resistance Point 18.98
1st Resistance Point 18.53
Last Price 18.08
1st Support Level 17.65
2nd Support Level 17.21
3rd Support Level 16.76

See More

52-Week High 25.62
Fibonacci 61.8% 18.72
Last Price 18.08
Fibonacci 50% 16.59
Fibonacci 38.2% 14.46
52-Week Low 7.57

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar